.Along with early period 1 data right now out in bush, metabolic disease outfit Metsera is losing no...
.Rivus Pharmaceuticals has actually revealed the information behind its stage 2 excessive weight win...
.Bristol Myers Squibb is paying out Top Medication $110 million beforehand to create reagents for ex...
.Novartis has inked an offer likely worth more than $1 billion with Flagship-founded Generate: Biome...
.Recently debuted Metsera is unfolding some period 1 information for its GLP-1 receptor agonist, sho...
.Amidst the genetic medications branches ethnicity, Front runner Pioneering is unveiling a brand new...
.BioAge Labs is actually looking at around $180 million in first earnings from an IPO and also a pri...
.An effort through Merck & Co. to uncover the microsatellite steady (MSS) metastatic colorectal c...
.Spain-based Asabys Allies has actually closed a fund of 180 thousand euros ($ 200 million), money t...
.BioAge Labs is bringing in just about $200 million via its Nasdaq IPO today, with the earnings set ...